The new instruments help advance the Intracept procedure for chronic vertebrogenic low back pain. Credit: Africa Studio / Shutterstock.com.

Relievant Medsystems has introduced next-generation Intracept Access Instruments for chronic vertebrogenic low back pain.

The instruments have been designed to provide predictable and accurate targeting of the basivertebral nerve (BVN) during the Intracept procedure.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

Relievant’s minimally invasive Intracept procedure is claimed to be the only US Food and Drug Administration-approved treatment for chronic vertebrogenic low back pain.

The new Intracept Access instruments are said to offer predictable performance across several bone densities.

These instruments include Bevel and Diamond Introducers to facilitate consistent access with a depth marker for optimal positioning.

See Also:

The Curved Cannula Assembly with J-Stylet enables true steerability for creating a predictable path to the BVN.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The Straight Stylet instrument helps extend or change the access path trajectory.

Designed to offer targeted radiofrequency energy, the IntraceptRF Probe now has a flexible shaft to enhance C-arm operating clearance.

Relievant Medsystems president and CEO Tyler Binney said: “Today, we are pleased to announce the launch of several new instruments offering greater control, precision and ease of use during the procedure.

“These next-generation Intracept Access Instruments are purpose-built to enhance BVN access and procedural efficiency while consistently delivering positive outcomes.”

More than 10,000 patients received treatment with Relievant’s same-day outpatient Intracept procedure that makes use of targeted radiofrequency energy for stopping the transmission of pain signals by BVN to the brain.